Blue Nile Announces First Quarter 2015 Financial Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Blue Nile Announces First Quarter 2015 Financial Results

First Quarter Net Sales of $106.5 million

First Quarter Earnings Per Diluted Share Total $0.10

SEATTLE, May 8, 2015 (GLOBE NEWSWIRE) -- Blue Nile, Inc. (Nasdaq: NILE ), a leading online retailer of diamonds and fine jewelry, today reported financial results for its first quarter ended April 5, 2015.

Net sales increased 2.6% to $106.5 million for the first quarter ended April 5, 2015 compared to $103.7 million for the first quarter ended March 30, 2014. Operating income for the quarter totaled $1.9 million, representing an operating margin of 1.8% of net sales compared to $1.6 million of operating income and 1.6% of operating margin for the first quarter of 2014. Net income totaled $1.2 million, or $0.10 per diluted share versus $1.1 million, or $0.08 per diluted share for the first quarter of 2014.

Non-GAAP adjusted EBITDA for the quarter totaled $4.0 million compared to $3.6 million for the first quarter of 2014. For the trailing twelve month period ended April 5, 2015, net cash provided by operating activities totaled $10.5 million compared to $24.0 million for the trailing twelve month period ended March 30, 2014. For the trailing twelve month period ended April 5, 2015, non-GAAP free cash flow totaled $6.6 million, as compared to $18.8 million for the trailing twelve month period ended March 30, 2014.

"In the first quarter, we meaningfully expanded profitability while making even greater investments in marketing and pricing as we looked to grow the business. While sales growth was modest, we drove solid performance in an industry that is experiencing overall challenges," said Harvey Kanter, Blue Nile Chairman, CEO and President. "Looking forward, we will continue to drive our investments in pricing, while also creating more specialized marketing, promoting designer relationships, and executing our Webroom concept, in order to build greater trust and compel consumers to move online."

Highlights

  • U.S. engagement net sales for the first quarter 2015 increased 2.1% to $61.0 million, compared to $59.7 million for the first quarter of 2014.  
  • U.S. non-engagement net sales for the first quarter 2015 decreased 0.3% to $26.0 million, compared to $26.1 million for the first quarter of 2014.  
  • International net sales for the first quarter 2015 were $19.5 million, compared to $17.9 million for the first quarter 2014, an increase of 8.6%. Excluding the impact from changes in foreign exchange rates, international net sales increased 16.4%.  
  • Gross profit for the first quarter 2015 totaled $20.0 million. As a percent of net sales, gross profit was 18.8% compared to 18.4% for the first quarter of 2014.  
  • Selling, general and administrative expenses for the first quarter 2015 were $18.1 million, compared to $17.5 million in the first quarter of 2014. Selling, general and administrative expenses includes stock-based compensation expense of $1.2 million for the first quarter in 2015 and $1.1 million for the first quarter in 2014.  
  • Earnings per diluted share for the first quarter of 2015 was $0.10 compared to $0.08 for the first quarter 2014.  Earnings per diluted share included stock-based compensation expense of $0.07 for the first quarter 2015 and $0.06 for the first quarter 2014.  
  • At the end of the first quarter 2015, cash and cash equivalents totaled $39.7 million.

Financial Guidance

The following forward-looking statements reflect Blue Nile's expectations as of May 8, 2015. Actual results may be materially affected by many factors, such as consumer spending, economic conditions and the various factors detailed below.

Expectations for the second quarter of 2015 (Quarter Ending July 5, 2015):

  • Net sales are expected to be between $110 million and $113 million.
  • Earnings per diluted share are projected at $0.18 to $0.21.

Expectations for the fiscal year 2015 (Year Ending January 3, 2016):

  • Net sales are expected to be between $488 million and $505 million.
  • Earnings per diluted share are projected at $0.83 to $0.93.

Blue Nile reports fiscal results on a 52/53-week format. The Company's fiscal 2014 reporting period includes 53 weeks, with an additional week falling into the fourth quarter.

Forward-Looking Statements

This press release contains forward-looking statements that include risks and uncertainties, including, without limitation, all statements related to future financial and business performance, market opportunity and plans to grow our business. Words such as "expect," "anticipate," "believe," "project," "will" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon our current expectations. Forward-looking statements involve risks and uncertainties. Our actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to commodity prices, general economic conditions, consumer spending (particularly spending by high-end consumers), product assortment, our fluctuating operating results, currency fluctuations, seasonality in our business, our ability to acquire products on reasonable terms, our online business model, demand for our products, our ability to attract customers in a cost effective manner, the strength of our brand, competition, fraud, system interruptions, our ability to fulfill orders and other risks detailed in our filings with the Securities and Exchange Commission, including our quarterly reports on Form 10-Q and our Annual Report on Form 10-K for the year ended January 4, 2015. Additional information will also be set forth in our Quarterly Report on Form 10-Q for the quarter ended April 5, 2015, which we expect to file with the Securities and Exchange Commission on or before May 15, 2015. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement, and Blue Nile undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date hereof.

Conference Call

Blue Nile will host a conference call to discuss its first quarter financial results today at 5:30 a.m. PT/8:30 a.m. ET. A live webcast of the conference call may be accessed at  http://investor.bluenile.com . Following the completion of the call, a recorded replay of the webcast will be available for 30 days at the same Internet address. This call will contain forward-looking statements and other material information regarding Blue Nile's financial and operating results. In the event that any non-GAAP financial measure is discussed on the conference call that is not described in this release, related complementary information will be made available at http://investor.bluenile.com as soon as practicable after the conclusion of the conference call.

Non-GAAP Financial Measures

To supplement Blue Nile's consolidated financial statements presented in accordance with generally accepted accounting principles ("GAAP"), Blue Nile uses non-GAAP adjusted EBITDA and non-GAAP free cash flow as measures of certain components of financial performance. Blue Nile defines non-GAAP adjusted EBITDA as earnings before interest and other income, taxes, depreciation and amortization, adjusted to exclude the effects of stock-based compensation expense. Blue Nile defines non-GAAP free cash flow as net cash provided by (used in) operating activities less cash outflows for purchases of fixed assets, including internal-use software and website development. Blue Nile reports sales information in accordance with GAAP. Internally, management monitors its sales performance on a non-GAAP basis that eliminates the positive or negative effects that result from translating international sales into U.S. dollars (the "constant exchange rate basis"). Blue Nile's management does not itself, nor does it suggest that investors should, consider such non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Investors should also note that the non-GAAP financial measures used by Blue Nile may not be the same non-GAAP financial measures, and may not be calculated in the same manner, as that of other companies. Whenever Blue Nile uses such non-GAAP financial measures, it provides a reconciliation of non-GAAP financial measures to the most closely applicable GAAP financial measures. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures.

Blue Nile's management believes that non-GAAP adjusted EBITDA and non-GAAP free cash flow, as defined, as well as international sales on a constant exchange rate basis provide meaningful supplemental information to the company and to investors. Blue Nile believes that both management and investors benefit from referring to these non-GAAP measures in assessing the performance of Blue Nile and when planning and forecasting future periods. Further, management believes that the inclusion of the non-GAAP adjusted EBITDA and non-GAAP free cash flow calculations provide consistency in Blue Nile's financial reporting and comparability with similar companies in Blue Nile's industry. Management believes the constant exchange rate measurement provides a more representative assessment of the sales performance and provides better comparability between reporting periods.

A reconciliation of non-GAAP adjusted EBITDA to net income is as follows (in thousands):

  Quarter ended April 5, 2015 Quarter ended March 30, 2014
Net income  $ 1,187  $ 1,079
Income tax expense 676 575
Other expense (income), net 47 (46)
Depreciation and amortization 904 922
Stock-based compensation 1,208 1,081
Non-GAAP adjusted EBITDA  $ 4,022  $ 3,611

A reconciliation of differences of non-GAAP free cash flow from the comparable GAAP measure of net cash (used in) provided by operating activities is as follows (in thousands):

  Quarter ended April 5, 2015 Quarter ended March 30, 2014
Net cash used in operating activities  $ (50,484)  $ (43,809)
Purchases of fixed assets, including internal-use software and website development (799) (628)
Non-GAAP free cash flow  $ (51,283)  $ (44,437)
     
     
  Twelve months ended April 5, 2015 Twelve months ended March 30, 2014
Net cash provided by operating activities  $ 10,533  $ 24,035
Purchases of fixed assets, including internal-use software and website development (3,942) (5,245)
Non-GAAP free cash flow  $ 6,591  $ 18,790

The following table reconciles year-over-year international net sales percentage increases (decreases) from the GAAP sales measures to the non-GAAP constant exchange rate basis:

Quarter ended April 5, 2015 Year over year growth Effect of foreign exchange movements Year over year growth on constant exchange rate basis
International net sales 8.6% (7.8%) 16.4%
Quarter ended March 30, 2014 Year over year growth Effect of foreign exchange movements Year over year growth on constant exchange rate basis
International net sales 1.9% (4.5%) 6.4%

About Blue Nile, Inc.

Blue Nile, Inc. is the original online jeweler. The company offers a smarter way to buy engagement rings, wedding rings, and fine jewelry by providing in-depth educational materials and unique online tools that place consumers in control of the jewelry shopping process. Blue Nile has some of the highest quality standards in the industry and offers thousands of independently certified diamonds and fine jewelry at prices significantly below traditional retail. Blue Nile can be found online at www.bluenile.com . Blue Nile's shares are traded on the Nasdaq Stock Market LLC under the symbol NILE.

BLUE NILE, INC.
Condensed Consolidated Balance Sheets
(unaudited)
(in thousands)
       
  April 5, 2015 January 4, 2015 March 30, 2014
       
ASSETS      
Current assets:      
Cash and cash equivalents  $ 39,657  $ 91,186  $ 56,713
Trade accounts receivable, net 2,801 2,137 2,856
Other accounts receivable 1,206 1,571 255
Inventories 38,349 41,668 35,181
Deferred income taxes 988 1,123 711
Prepaid income taxes 196 — 627
Prepaids and other current assets 1,345 1,524 1,488
Total current assets 84,542 139,209 97,831
Property and equipment, net 10,319 10,422 9,945
Intangible assets, net 98 103 130
Deferred income taxes 3,237 3,064 5,526
Note receivable 2,000 2,000 2,000
Other investments 2,280 2,280 2,280
Other assets 232 256 241
Total assets  $ 102,708  $ 157,334  $ 117,953
LIABILITIES AND STOCKHOLDERS' EQUITY      
Current liabilities:      
Accounts payable  $ 77,763  $ 128,675  $ 81,876
Accrued liabilities 6,262 11,992 5,614
Current portion of long-term financing obligation 32 32 36
Current portion of deferred rent 295 292 281
Total current liabilities 84,352 140,991 87,807
Long-term financing obligation, less current portion 480 489 574
Deferred rent, less current portion 1,913 1,982 2,170
Other long-term liabilities 168 169 114
Commitments and contingencies      
Stockholders' equity:      
Common stock 22 22 22
Additional paid-in capital 228,189 227,146 225,399
Accumulated other comprehensive loss (374) (236) (32)
Retained earnings 104,676 103,489 94,837
Treasury stock (316,718) (316,718) (292,938)
Total stockholders' equity 15,795 13,703 27,288
Total liabilities and stockholders' equity  $ 102,708  $ 157,334  $ 117,953
 
BLUE NILE, INC.
Condensed Consolidated Statements of Operations
(unaudited)
(in thousands, except per share data)
     
  Quarter ended
  April 5, 2015 March 30, 2014
Net sales  $ 106,447  $ 103,726
Cost of sales 86,474 84,601
Gross profit 19,973 19,125
Selling, general and administrative expenses 18,063 17,517
Operating income 1,910 1,608
Other (expense) income, net    
Interest income, net 36 48
Other expense, net (83) (2)
Total other (expense) income, net (47) 46
Income before income taxes 1,863 1,654
Income tax expense 676 575
Net income  $ 1,187  $ 1,079
Basic net income per share  $ 0.10  $ 0.08
Diluted net income per share  $ 0.10  $ 0.08
     
Shares used for computation (in thousands):    
Basic 11,869 12,800
Diluted 11,923 12,913
 
BLUE NILE, INC.
Condensed Consolidated Statements of Cash Flows
(unaudited)
(in thousands)
     
  Quarter ended
  April 5, 2015 March 30, 2014
Operating activities:    
Net income  $ 1,187  $ 1,079
Adjustments to reconcile net income to net cash used in operating activities:    
Depreciation and amortization 904 922
Stock-based compensation 1,218 1,101
Deferred income taxes (38) 271
Tax (deficiency) benefit from exercise of stock options (36) 103
Excess tax benefit from exercise of stock options — (155)
Changes in assets and liabilities:    
Receivables (299) 415
Inventories 3,319 (651)
Prepaid federal income taxes (196) (380)
Prepaid expenses and other assets 203 (165)
Accounts payable (50,949) (41,155)
Accrued liabilities (5,730) (5,137)
Deferred rent and other (67) (57)
Net cash used in operating activities (50,484) (43,809)
Investing activities:    
Purchases of property and equipment (799) (628)
Net cash used in investing activities (799) (628)
Financing activities:    
Repurchase of common stock — (15,836)
Proceeds from stock option exercises — 1,084
Taxes paid for net share settlement of equity awards (168) (176)
Excess tax benefit from exercise of stock options — 155
Principal payments under long-term financing obligation (9) (15)
Net cash used in financing activities (177) (14,788)
     
Effect of exchange rate changes on cash and cash equivalents (69) (4)
     
Net decrease in cash and cash equivalents (51,529) (59,229)
     
Cash and cash equivalents, beginning of period 91,186 115,942
Cash and cash equivalents, end of period  $ 39,657  $ 56,713
     
  Quarter ended
  April 5, 2015 March 30, 2014
Supplemental disclosure of cash flow information:    
Cash paid for income taxes  $ 2,253  $ 582
Non-cash investing and financing activities:    
Unsettled repurchases of common stock $ —  $ 692

Blue Nile, Inc. Nancy Shipp, 206.388.3626 (Investors) or Josh Holland, 206.336.6773 (Media)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 307

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 211

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 246

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 694

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 63

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 351

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 239

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 27

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 180

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

HD Hyundai Sparks Fusion Hopes with ITER Milestone

Updated Category News Views 9

Hold on to Your Hard Hats, Fusion Milestone Achieved Look who's making waves in the world of nuclear fusion. HD Hyundai Heavy Industries has hit a crucial benchmark in the ITER nuclear fusion project. This ain't your run-of-the-mill accomplishment, folks. We're talking about completing the assembly of some of the most complex and intricately designed machinery known to...

Continue Reading
ChemoMetec Boosts Financial Outlook with Anticipated Growth

Updated Category News Views 353

ChemoMetec Boosts Financial Outlook Amid Growing Interest ChemoMetec is excited to announce an upgrade in its financial guidance as the company sees a growing demand for its pioneering technologies, particularly the highly regarded XcytoMatic platform. This surge in interest bodes well for the company's revenue and profit, reflecting a positive trajectory as it approaches...

Continue Reading
GDS Holdings Completes Successful C-REIT IPO on Shanghai Exchange

Updated Category News Views 200

GDS Holdings Limited Celebrates C-REIT IPO Success GDS Holdings Limited, known as GDS, is thrilled to announce that it has successfully completed its initial public offering of its China REIT, or C-REIT, on the Shanghai Stock Exchange. This milestone marks an exciting moment for the company and its stakeholders as market interest surpassed expectations. Highlighting the...

Continue Reading
Innovative E-Waste Solutions from Techbros Redefine Recycling

Updated Category News Views 273

AI-Driven E-Waste Innovation from Techbros In a remarkable leap towards sustainability and innovative technology, Techbros Electronic Recycling proudly announces the launch of the Southwest's first fully integrated AI-driven IT asset disposition (ITAD) and e-waste processing facility. This state-of-the-art facility exemplifies the future of electronics recycling by...

Continue Reading
SageSure Welcomes Insurance Veteran Peter Hearn to Board

Updated Category News Views 268

SageSure Welcomes New Board Member SageSure, one of the largest managing general underwriters that focus on markets exposed to catastrophe risks, has taken a significant step by appointing Peter Hearn to its Board of Managers. This strategic move is anticipated to bolster the company’s leadership and industry insights. Peter Hearn's Impressive Background Peter Hearn...

Continue Reading